# Abbvie (ABBV): value investors who own it | moatshark

7 value investors held Abbvie in their Q3 2026 13F, led by Matrix Asset Advisors, Mairs & Power, Jensen Investment Management, Horizon Kinetics, Gardner…

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Matrix Asset Advisors | 0.7% | $8.9m | Trimmed -13% | 27 |
| Mairs & Power | 0.1% | $11.2m | Trimmed -1.4% | 53 |
| Jensen Investment Management | 0.1% | $2.8m | Trimmed -0.7% | 53 |
| Horizon Kinetics | 0.1% | $4.8m | Trimmed -1.7% | 30 |
| Gardner Russo & Quinn | 0.0% | $3.1m | Unchanged | 53 |
| Dodge & Cox | 0.0% | $2.6m | Unchanged | 53 |
| Harris Associates (Oakmark) | 0.0% | $609k | Trimmed -9.8% | 5 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-08-14 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sold | 32710 | $8.2m |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/abbv). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.